Behcet Disease Follow-up

Updated: Dec 11, 2018
  • Author: Nicole Davey-Ranasinghe, MD; Chief Editor: Herbert S Diamond, MD  more...
  • Print
Follow-up

Further Outpatient Care

As disease activity subsides, taper medications to the lowest dose that effectively controls the symptoms and disease activity.

Next:

Further Inpatient Care

Inpatient care is based on individual organ-system involvement.

In general, no further care is needed.

Previous
Next:

Inpatient & Outpatient Medications

Inpatient and outpatient medication are the same (see Medication). All agents discussed above have been found to be effective in controlling the manifestations of Behçet disease.

Previous
Next:

Transfer

Individualize the transfer situation for each patient based on the specifics of organ-system involvement.

Previous
Next:

Deterrence/Prevention

Continual use of immunosuppressive medications may be required to suppress disease. Use the lowest dose required to control the manifestations of illness.

Previous
Next:

Complications

Aneurysms are especially feared.

Thrombotic events and vasculitis may lead to ischemia distal to vascular lesions.

Uncontrolled ophthalmologic involvement in the form of anterior and posterior uveitis can lead to vision loss.

Neurologic involvement suggests progressive disease and can lead to permanent deficits or even death.

Previous
Next:

Prognosis

Prognosis is related to the site and severity of involvement.

Previous
Next:

Patient Education

For patient education information, see the Arthritis Center, Eye and Vision Center, and Teeth and Mouth Center. Also, see Canker Sores, Inflammatory Bowel Disease, and Iritis.

Previous